Neurology & CNS Research
Neurology
Neurological disorders affect millions worldwide, creating a critical need for innovative research and advanced treatments. CenExel is committed to accelerating neurology clinical trials by partnering with sponsors to deliver high-quality data and improved patient outcomes across diverse populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Leading Neurology Clinical Research
Complex neurological trials require specialized expertise and advanced infrastructure. CenExel’s neurology research team integrates scientific, recruitment, and operational excellence to ensure seamless study execution from first patient in to last patient out.
Our sites are equipped to conduct early and late-phase trials, leveraging advanced imaging technologies, biomarker analysis, and experienced investigators to deliver high-quality outcomes—even for complex central nervous system (CNS) conditions.
We support a wide range of neurological conditions including neurodegenerative diseases, movement disorders, and rare CNS indications across adult and geriatric populations.
Conditions Covered
Neurological Conditions We Research
Our neurology research sites support a broad spectrum of conditions—from common neurological disorders to rare and complex CNS diseases.
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis (MS)
Epilepsy
Migraine Disorders
Stroke Recovery
Amyotrophic Lateral Sclerosis (ALS)
Neuropathic Pain
Huntington’s Disease
Traumatic Brain Injury (TBI)
Our Approach
Why Sponsors Choose CenExel for Neurology
CenExel supports neurological trials across neurodegenerative diseases, movement disorders, epilepsy, and rare CNS conditions, with a specialized team ensuring accurate execution, patient safety, and high-quality data.
01
Expert CNS Investigators
Our experienced neurologists and research teams ensure accurate diagnosis, protocol adherence, and high-quality data collection.
02
Advanced Imaging & Biomarkers
We utilize cutting-edge imaging technologies and biomarker strategies to enhance study precision and early decision-making.
03
Diverse Patient Access
Access to diverse patient populations across multiple regions supports faster enrollment and representative study data.
04
High Enrollment Performance
Our in-house recruitment teams consistently achieve strong enrollment rates through targeted outreach and patient engagement strategies.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase neurology clinical trials—from first-in-human and proof-of-concept studies through Phase IV post-marketing research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
View More
Therapeutic Area
Metabolic
CenExel partners with pharmaceutical and biotechnology sponsors to accelerate obesity, diabetes, and metabolic
Therapeutic Area
Pain
Chronic and acute pain affect millions of individuals worldwide, significantly impacting quality of life.
Therapeutic Area
Psychiatry
In the U.S., 20% of the population suffers from mental illness, creating a critical need for innovative treatments.